The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard ...

Gritstone Bio announced it is “taking action” to “preserve value and strengthen capital structure” on Thursday.

Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...

As the battle over Pfizer’s future continues, former executives said they would no longer support activist investor Starboard ...

Hedge fund Starboard Value's activist campaign targeting Pfizer (PFE) divides Wall Street, with analysts questioning the ...

Starboard said a former CEO and CFO had assisted in its activist campaign but then were pressured to express support for the ...

Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current CEO ...

The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the ...

The overall survival data from the late-stage trial will help Pfizer in its bid to expand the label for Talzenna and Xtandi, ...

Ex-CEO Ian Read and former CFO Frank D’Amelio said they are “fully supportive” of Pfizer’s current CEO, senior management and ...

Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...

Pfizer shared that the combination of its drugs Talzenna and Xtandi extended survival in men with metastatic ...